Results 141 to 150 of about 69,179 (216)

Is Enhancer Function Driven by Protein–Protein Interactions? From Bacteria to Leukemia

open access: yesBioEssays, Volume 47, Issue 6, June 2025.
Enhancers are key regulatory elements that are conceptually conserved from bacteria to humans. Enhancer dysregulation is common in cancers, including leukemia. We argue that highly specific protein–protein interactions, including transcription factors, mediate enhancer‐promoter proximity to allow enhancer‐bound factors to directly act on RNA polymerase
Nicholas T. Crump, Thomas A. Milne
wiley   +1 more source

Histone tetrasome dynamics affects chromatin transcription. [PDF]

open access: yesNucleic Acids Res
Shi X   +12 more
europepmc   +1 more source

A snapshot of the role of estrogen‐regulated divergent non‐coding transcripts

open access: yesClinical and Translational Discovery, Volume 5, Issue 3, June 2025.
The expansion of genome‐wide studies has identified widespread transcription that may result in previously unstudied transcripts, such as divergent long non‐coding RNAs. Abstract Recent high‐throughput sequencing technologies have discovered various polymerase II transcribed transcripts.
Barbara Yang   +16 more
wiley   +1 more source

Plasma H3.1 nucleosomes as biomarkers of infection, inflammation and organ failure. [PDF]

open access: yesCrit Care
Filippini DFL   +8 more
europepmc   +1 more source

Antisenescence therapies for age‐related bone loss: Target factors, medicines, biomedical materials

open access: yesClinical and Translational Medicine, Volume 15, Issue 6, June 2025.
With extended lifespans causing population aging, bone aging has become a worldwide issue. Cellular senescence in the bone microenvironment causes bone degeneration and dysfunction. This review summarises targets in cellular senescence and bone aging while detailing potential therapeutic strategies, including novel medicines and innovative biomedical ...
Qiyue Zhu   +6 more
wiley   +1 more source

Regulation of Genome Architecture in Huntington's Disease. [PDF]

open access: yesBiochemistry
Portillo-Ledesma S, Hang M, Schlick T.
europepmc   +1 more source

Halymenia durvillei Extracts Exert Antiobesity Effects by Targeting hosl‐1‐Mediated Lipolysis in a Glucose‐Induced Caenorhabditis elegans Model

open access: yeseFood, Volume 6, Issue 3, June 2025.
This study demonstrates the antiobesity potential of Halymenia durvillei (H. durvillei) extracts using a Caenorhabditis elegans (C. elegans) obesity model. The extracts significantly reduced total fat accumulation, lowered reactive oxygen species (ROS) levels, and extended the lifespan in glucose‐fed C. elegans. These beneficial effects may be mediated
Kawita Chumphoochai   +8 more
wiley   +1 more source

The INO80 Chromatin Remodeling Complex Regulates Histone H2A.Z Mobility and the G1‐S Transition in Oligodendrocyte Precursors

open access: yesGlia, Volume 73, Issue 6, Page 1307-1323, June 2025.
Main Points Inactivating the INO80 chromatin remodelling complex greatly extends the oligodendrocyte precursor (OP) cell cycle by prolonging G1. INO80 acts in OPs via histone H2A/H2A.Z exchange. INO80 binds the transcriptional regulator OLIG2 in OPs.
Jordan L. Wright   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy